Stockscreener 앱 받기
2.36
3.67%
-0.09
시간 외 거래:
2.34
-0.02
-0.85%
전일 마감가:
$2.45
열려 있는:
$2.47
하루 거래량:
78,779
Relative Volume:
0.65
시가총액:
$90.54M
수익:
$65.36M
순이익/손실:
$-22.90M
주가수익비율:
-4.7266
EPS:
-0.4993
순현금흐름:
$-20.54M
1주 성능:
-7.09%
1개월 성능:
-12.92%
6개월 성능:
-64.83%
1년 성능:
-49.46%
1일 변동 폭
$2.34
$2.6385
1주일 범위
$2.34
$2.66
52주 변동 폭
$2.27
$8.50
Edap Tms S A Adr Stock (EDAP) Company Profile
EDAP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| EDAP | 2.36 | 90.54M | 65.36M | -22.90M | -20.54M | -0.4993 |
| MCK | 615.60 | 79.62B | 330.19B | 2.54B | 4.31B | 25.31 |
| COR | 242.87 | 47.83B | 293.96B | 1.51B | 3.00B | 8.53 |
| CAH | 120.03 | 29.14B | 224.34B | 1.26B | 1.08B | 0.61 |
| HSIC | 73.89 | 9.36B | 12.50B | 314.00M | 421.00M | 3.42 |
| PDCO | 20.90 | 1.83B | 6.57B | 185.93M | -857.00M | 2.19 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-11-01 | 개시 | Jefferies | Buy |
| 2021-04-28 | 개시 | Piper Sandler | Overweight |
| 2020-04-15 | 개시 | B. Riley FBR | Buy |
| 2014-07-28 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2014-06-16 | 개시 | H.C. Wainwright | Buy |
| 2013-03-05 | 개시 | Northland Capital | Outperform |
| 2010-11-18 | 재확인 | Morgan Joseph | Buy |
| 2009-08-20 | 재확인 | Roth Capital | Hold |
| 2008-11-24 | 재확인 | Roth Capital | Hold |
| 2008-03-26 | 재확인 | Roth Capital | Hold |
| 2007-11-09 | 재확인 | Roth Capital | Hold |
| 2007-03-16 | 재확인 | Roth Capital | Hold |
| 2007-01-24 | 재확인 | Roth Capital | Hold |
모두보기
Edap Tms S A Adr 주식(EDAP)의 최신 뉴스
Earnings call: EDAP TMS sees growth with Focal One HIFU business - Investing.com
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Rockwell Medical On Expansion Spree: Should You Buy The Stock Now? - Barchart
EDAP TMS initiates BPH treatment study with Focal One HIFU - Investing.com
EDAP TMS initiates BPH treatment study with Focal One HIFU By Investing.com - Investing.com South Africa
Edap Tms (NASDAQ:EDAP) Upgraded to “Hold” at StockNews.com - Defense World
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures - GlobeNewswire Inc.
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap It Up Now? - Barchart
Ratio Review: Analyzing EDAP TMS S.A. ADR (EDAP)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Earnings call: EDAP TMS sees revenue growth, advances in HIFU technology - Investing.com
EDAP’s Stock Journey: What Investors Need to Know About EDAP TMS S.A. ADR’s Performance - The InvestChronicle
Ratio Revelations: EDAP TMS S.A. ADR (EDAP)’s Financial Metrics in the Spotlight - The Dwinnex
Robotic HIFU therapy shows safety but misses pain endpoint - Investing.com
U.S. Autoimmune Disease Diagnostics (Systemic, Localized) Market Size, Share & Trends Analysis Report 2024-2030 - GlobeNewswire Inc.
EDAP TMS appoints new board member - Investing.com
EDAP TMS appoints new board member By Investing.com - Investing.com India
LQR House posts 260% surge in June revenue - Investing.com
EDAP Provides Corporate Update on US Focal One® Installation Growth - The Globe and Mail
EDAP Announces Presentation at the Jefferies Virtual London Healthcare Conference - The Globe and Mail
EDAP Provides Corporate Update on US Focal One Installation Growth - The Globe and Mail
Zacks.com featured highlights include Immunocore Holdings, Old Second Bancorp, EDAP TMS, Barrett Business ... - Yahoo News UK
EDAP shares hold as analyst reiterates $19 target on growth By Investing.com - Investing.com
Earnings call: EDAP TMS reports robust Q1 2024 results, HIFU growth By Investing.com - Investing.com
EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary - The Globe and Mail
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues - Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer I - Benzinga
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The SpotlightiShares - Benzinga
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga
The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenicsMacrogenic - Benzinga
36 Biggest Movers From FridayAssembly Biosciences (NASDAQ:ASMB) - Benzinga
7 Stocks To Watch For June 8, 2018Edap TMS (NASDAQ:EDAP), Broadcom (NASDAQ:AVGO) - Benzinga
Edap Tms (EDAP) Stock Price, News & Analysis - MarketBeat
Petróleo Brasileiro S.A.Petrobras (PBR) Stock Price, News & Analysis - MarketBeat
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Edap Tms S A Adr (EDAP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
5.26%
자본화:
|
볼륨(24시간):